Skip to content

The library

149 compounds. Every one graded.

Filter by research area or by how strong the evidence actually is. Profiles graded Animal or Anecdotal are not hidden they are labelled, which is more useful.

Clinical
15
Human-limited
61
Animal
54
Anecdotal
19

26 of 149 profiles

Recovery

Erythropoietin (EPO)

Clinical

Oxygen-boosting hormone for endurance and anemia

Erythropoietin (EPO) is a glycoprotein hormone naturally produced primarily by the kidneys that regulates red blood cell production. Recombinant human EPO (rHuEPO) mimics this endogenous hormone to stimulate erythropoiesis in the bone marrow, increasing oxygen-carrying capacity. It is clinically approved for anemia associated with chronic kidney disease, chemotherapy, and certain other conditions, but is also widely misused as a performance-enhancing agent in endurance sports.

0 RCT · 0 human · 0 preclinical

Cardiovascular

Human Growth Hormone (HGH)

Clinical

The master anabolic and lipolytic growth hormone

Human Growth Hormone (HGH) is a 191-amino acid peptide hormone naturally secreted by the anterior pituitary gland that regulates growth, body composition, and metabolism. In clinical and performance contexts, recombinant HGH (rhGH) is administered exogenously to mimic or augment endogenous GH signaling. It is one of the most studied anabolic and lipolytic compounds in endocrinology, with established uses in GH deficiency, muscle-wasting conditions, and anti-aging protocols.

0 RCT · 0 human · 0 preclinical

growth

BPC-157 (Recovery)

Human-limited

Pentadecapeptide for rapid recovery from injury

Body protection compound for tissue repair & recovery acceleration.

0 RCT · 0 human · 0 preclinical

Recovery

Cardiogen

Human-limited

Cardiac peptide bioregulator for heart longevity

Cardiogen is a short synthetic tetrapeptide (Ala-Glu-Asp-Arg) originally developed by the St. Petersburg Institute of Bioregulation and Gerontology in Russia, designed to support cardiac tissue health and function. It acts as a cytoprotective bioregulator targeting cardiomyocytes, promoting cellular repair and reducing age-related deterioration in heart muscle tissue. Research, primarily from Russian preclinical and limited clinical studies, suggests it may help maintain cardiac contractility, reduce fibrosis, and support overall cardiovascular resilience.

0 RCT · 0 human · 0 preclinical

Cardiovascular

CJC-1295 (No DAC) + Ipamorelin 5mg Blend

Human-limited

Synergistic GH pulse amplifier for body and recovery

CJC-1295 (without DAC) + Ipamorelin is a synergistic peptide blend combining a growth hormone-releasing hormone (GHRH) analogue with a selective growth hormone secretagogue. Together, they stimulate the pituitary gland to release growth hormone in a pulsatile, physiologically natural manner. This combination is widely used for body composition improvement, recovery, anti-aging, and sleep quality enhancement.

0 RCT · 0 human · 0 preclinical

growth

CJC-1295 (Without DAC)

Human-limited

Natural GH Pulses for Growth and Recovery

CJC-1295 without DAC (also known as Modified GRF 1-29) is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone in a pulsatile, physiologically natural pattern. It consists of the first 29 amino acids of GHRH with four key amino acid substitutions that enhance stability and receptor affinity compared to the native peptide. It is widely used in research settings for its potential to promote lean muscle growth, fat loss, recovery, and anti-aging effects.

0 RCT · 0 human · 0 preclinical

growth

CJC-1295 with DAC

Human-limited

Long-acting GHRH analog for sustained GH release

CJC-1295 with DAC is a synthetic, long-acting analog of growth hormone-releasing hormone (GHRH) that incorporates a Drug Affinity Complex (DAC) to dramatically extend its half-life. By binding covalently to serum albumin, it maintains sustained elevation of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) for up to two weeks per injection. It is used in research settings to study GH secretion, body composition changes, and recovery processes.

0 RCT · 0 human · 0 preclinical

growth

GHK-Cu (Recovery)

Human-limited

Copper tripeptide for recovery and repair

Copper peptide for tissue remodeling & recovery.

0 RCT · 0 human · 0 preclinical

Recovery

Ipamorelin

Human-limited

GH-releasing peptide for lean mass and recovery

A selective growth hormone secretagogue and ghrelin mimetic that stimulates pituitary GH release with high specificity and minimal effect on cortisol or prolactin.

0 RCT · 0 human · 0 preclinical

growth

Thymalin/Thymulin

Human-limited

Thymic peptide restoring immune vitality with age

Thymalin is a thymic peptide preparation derived from calf thymus glands, while Thymulin (FTS) is a naturally occurring nonapeptide produced by thymic epithelial cells that requires zinc as a cofactor for biological activity. Together they represent thymic-origin immunomodulatory compounds that restore and regulate T-lymphocyte differentiation, maturation, and function. They are used primarily to support immune system integrity, combat immunosenescence, and may have applications in anti-aging and recovery protocols.

0 RCT · 0 human · 0 preclinical

Immune

B7-33

Animal

Biased RXFP1 agonist for cardiac fibrosis

B7-33 is a single-chain peptide analog of human relaxin-2, engineered to selectively activate the RXFP1 receptor without triggering the cAMP signaling pathway. It demonstrates potent anti-fibrotic, vasodilatory, and cardioprotective effects in preclinical models. Research primarily focuses on its potential in heart failure, pulmonary arterial hypertension, and organ fibrosis.

0 RCT · 0 human · 0 preclinical

Cardiovascular

BPC-157

Animal

Systemic healing for wounds, tendons, and gut

A synthetic pentadecapeptide derived from a protein in gastric juice, studied for tissue repair, gut protection, and musculoskeletal healing.

0 RCT · 0 human · 0 preclinical

healing

BPC-157 + TB-500 Blend (10mg + 10mg)

Animal

Synergistic healing and recovery peptide blend

BPC-157 + TB-500 is a pre-mixed peptide blend combining Body Protection Compound-157 (a gastric pentadecapeptide) and Thymosin Beta-4 fragment (TB-500) into a single vial for convenience. Together, these two peptides target overlapping and complementary pathways in tissue repair, angiogenesis, and inflammation modulation. The combination is widely used in the research and biohacking communities for accelerated musculoskeletal recovery, tendon and ligament healing, and systemic anti-inflammatory effects.

0 RCT · 0 human · 0 preclinical

Recovery

BPC-157 + TB-500 Blend (5mg + 5mg)

Animal

Synergistic repair blend for accelerated healing

BPC-157 + TB-500 is a synergistic peptide blend combining Body Protection Compound-157 (5mg) and Thymosin Beta-4 fragment TB-500 (5mg) into a single vial. BPC-157 is a synthetic pentadecapeptide derived from a protective gastric protein, while TB-500 is a synthetic analog of the actin-sequestering protein Thymosin Beta-4, both of which promote tissue repair and regeneration. Together, they are widely used in research for accelerated healing of musculoskeletal injuries, tendons, ligaments, and soft tissue damage.

0 RCT · 0 human · 0 preclinical

Recovery

Crystagen

Animal

Ocular cytoprotection via crystallin chaperone mimicry

Crystagen is a synthetic peptide derived from the alpha-crystallin protein family, small heat-shock proteins (sHSPs) naturally abundant in the eye lens. It is investigated primarily for its cytoprotective and anti-apoptotic properties in ocular tissues, with emerging research suggesting neuroprotective and anti-inflammatory effects. Evidence is largely limited to animal and in vitro models, and no approved clinical use currently exists.

0 RCT · 0 human · 0 preclinical

eye

Dermorphin

Animal

Potent frog-derived mu-opioid receptor agonist

Dermorphin is a naturally occurring heptapeptide opioid first isolated from the skin of South American Phyllomedusa frogs. It binds with extraordinarily high selectivity and potency to mu-opioid receptors, producing analgesic effects estimated to be 30–40 times more potent than morphine on a molar basis. Research has primarily been conducted in animal models, with extremely limited controlled human data available.

0 RCT · 0 human · 0 preclinical

mood

FST 344

Animal

Myostatin blocker for serious muscle hypertrophy

FST 344 is a recombinant isoform of follistatin, a naturally occurring glycoprotein that binds and neutralizes myostatin and activin, two potent inhibitors of muscle growth. By suppressing these negative regulators, FST 344 promotes skeletal muscle hypertrophy, enhances recovery, and may support bone density. It has been investigated in gene therapy and preclinical contexts for muscular dystrophy and sarcopenia, though human clinical data remain very limited.

0 RCT · 0 human · 0 preclinical

growth

GHRP-3

Animal

Third-generation GH secretagogue with refined selectivity

GHRP-3 is a synthetic hexapeptide and member of the growth hormone releasing peptide family, designed to stimulate the pulsatile release of growth hormone (GH) from the anterior pituitary gland. It acts primarily as a ghrelin mimetic and GHS-R1a agonist, amplifying natural GH secretion pulses. GHRP-3 is structurally related to GHRP-2 and GHRP-6 but exhibits a modified amino acid sequence intended to reduce appetite-stimulating side effects while maintaining GH secretagogue potency.

0 RCT · 0 human · 0 preclinical

growth

GLOW (BPC-157 + GHK-Cu + TB-500 Blend)

Animal

Regenerate, Renew, Glow From Within

GLOW is a synergistic peptide blend combining BPC-157 (10mg), GHK-Cu (50mg), and TB-500 (10mg) into a single formulation designed to accelerate tissue repair, promote skin rejuvenation, and support systemic recovery. BPC-157 and TB-500 target musculoskeletal and gut healing, while GHK-Cu drives collagen synthesis, anti-inflammatory signaling, and skin remodeling. Together, these three peptides work across complementary pathways to produce enhanced regenerative and cosmetic outcomes.

0 RCT · 0 human · 0 preclinical

healing

Mechano Growth Factor (MGF)

Animal

Local muscle repair signal for accelerated recovery

Mechano Growth Factor (MGF) is a splice variant of Insulin-like Growth Factor 1 (IGF-1) that is produced locally in muscle and other tissues in response to mechanical stress or damage. It plays a critical role in activating satellite cells (muscle stem cells) to initiate repair and hypertrophy. MGF is primarily of interest to researchers studying muscle regeneration, athletic recovery, and tissue repair.

0 RCT · 0 human · 0 preclinical

growth

TB-500

Animal

Thymosin beta-4 fragment for wound repair

A synthetic fragment of Thymosin Beta-4, a naturally occurring protein involved in actin regulation, tissue repair, and inflammation modulation.

0 RCT · 0 human · 0 preclinical

healing

TB-500

Animal

Accelerate healing, reduce inflammation, restore mobility

TB-500 is a synthetic peptide fragment derived from Thymosin Beta-4, a naturally occurring protein found in virtually all human and animal cells. It promotes tissue repair, reduces inflammation, and accelerates healing of muscles, tendons, ligaments, and skin. It is widely used in research and sports recovery contexts for its potent regenerative properties.

0 RCT · 0 human · 0 preclinical

Recovery

TB-500 (Recovery)

Animal

Thymosin beta-4 for injury recovery

Thymosin beta-4 for systemic recovery & inflammation reduction.

0 RCT · 0 human · 0 preclinical

Recovery

Adamax

Anecdotal

Nootropic peptide blend for cognition and mood

Adamax is a research peptide blend reported to combine nootropic and neuroprotective peptide components aimed at enhancing cognitive function, mood stability, and neural recovery. It is marketed primarily for its potential effects on dopaminergic and serotonergic signaling pathways. Evidence is largely limited to preclinical and anecdotal sources, with no published human clinical trials specific to the Adamax formulation.

0 RCT · 0 human · 0 preclinical

cognition

GHRP-4

Anecdotal

Pituitary GH secretagogue for growth and recovery

GHRP-4 is a synthetic hexapeptide ghrelin mimetic designed to stimulate the pituitary gland's release of endogenous growth hormone. It belongs to the same family as GHRP-2 and GHRP-6 but is a less extensively characterized analog with a modified structure aimed at optimizing GH release with a potentially reduced appetite-stimulating side effect profile. Research on GHRP-4 specifically is limited compared to its better-studied relatives, and most mechanistic understanding is extrapolated from the broader GHRP class.

0 RCT · 0 human · 0 preclinical

growth

KLOW

Anecdotal

Electrolyte balance and cardiovascular metabolic support

KLOW is a research compound or proprietary peptide blend purported to support electrolyte balance, cardiovascular function, and cellular metabolic homeostasis. It is marketed within the peptide research space, though its precise composition and mechanism are not well-established in peer-reviewed literature. Evidence for its specific effects remains largely anecdotal and preclinical.

0 RCT · 0 human · 0 preclinical

metabolic

Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.